Auro Ear Wax Remover
NDC Package 63736-232-24
Package Information
Auro Ear Wax Remover is adults and children 12 years of age and oldertilt head sideways and place 5 to 10 drops into eartip of applicator should not enter ear canalkeep drops in ear for several minutes by keeping head tilted or placing cotton in the earuse twice daily for up to 4 days if needed or as directed by a doctorany wax remaining after treatment may be removed by gently flushing the ear with warm water, using a soft rubber bulb ear syringechildren under 12 years of age consult a doctor. Marketed by Insight Pharmaceuticals Llc, this product is identified by NDC 63736-232 and is authorized under FDA application part344.
Identification & Billing
- RxCUI: 702050 - carbamide peroxide 6.5 % Otic Solution
- RxCUI: 702050 - carbamide peroxide 65 MG/ML Otic Solution
- RxCUI: 827731 - AURO Earwax Removal Aid 6.5 % Otic Solution
- RxCUI: 827731 - carbamide peroxide 65 MG/ML Otic Solution [Auro Ear]
- RxCUI: 827731 - Auro Ear Drops 6.5 % Otic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 63736 - Insight Pharmaceuticals Llc
- 63736-232 - Auro Ear Wax Remover
- 63736-232-24 - 1 TUBE in 1 BOX / 22 mL in 1 TUBE
- 63736-232 - Auro Ear Wax Remover
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 63736-232-24 identifies a specific commercial package of 1 tube in 1 box / 22 ml in 1 tube of Auro Ear Wax Remover, labeled by Insight Pharmaceuticals Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Insight Pharmaceuticals Llc on July 01, 2010. The current certification is valid through December 31, 2017.
How is this Insight Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 63736023224. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.